文献速递慢阻肺

肺功能与血液DNA甲基化:多祖先表观基因组关联荟萃分析

Pulmonary Function and Blood DNA Methylation: A Multiancestry Epigenome-Wide Association Meta-analysis.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该研究纳入12个队列共17,503人,分析血液DNA甲基化与FEV1、FVC及FEV1/FVC的关联。共识别1,267个与肺功能相关的差异甲基化CpG位点(1,042个基因),其中1,240个为新发现,73个同时与慢阻肺相关。整合分析提示这些位点具有功能相关性并可能成为治疗靶点。

要点

  • 识别1,267个与肺功能相关的差异甲基化CpG位点,多数为新发现
  • 73个CpG位点同时与慢阻肺相关,部分基因是现有或在研药物靶点
  • 孟德尔随机化与共定位分析提示关联信号捕获因果调控基因组位点

核心结论

  • 研究识别大量与肺功能相关的新型差异甲基化位点,整合分析显示其功能相关性及潜在治疗靶点价值。

研究设计与样本

  • 12个队列的表观基因组-wide荟萃分析,共17,503人(欧洲14,761、非洲2,549、西班牙/拉丁裔193),使用Illumina 450K或EPIC/850K芯片检测血液DNA甲基化。

主要发现

  • 识别1,267个CpG(1,042个基因)与FEV1、FVC或FEV1/FVC差异甲基化相关(FDR<0.025),包括1,240个新位点和73个与慢阻肺(1,787例)相关的位点。
  • 发现294个仅见于欧洲或非洲祖先的CpG,以及395个仅见于从不吸烟或曾经吸烟者的CpG。
  • 多数显著CpG与血液中邻近基因表达相关,结果富集于血液和肺的染色质可及性等调控元件。
  • 孟德尔随机化与共定位分析提示EWAS信号捕获因果调控基因组位点。

临床怎么用

  • 这些位点多数未在大规模全基因组关联研究中检出,可为肺功能与慢阻肺机制研究提供新候选基因和潜在可干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Methylation integrates factors present at birth and modifiable across the lifespan that can influence pulmonary function. Studies are limited in scope and replication. Objectives: To conduct large-scale epigenome-wide meta-analyses of blood DNA methylation and pulmonary function. Methods: Twelve cohorts analyzed associations of methylation at cytosine-phosphate-guanine probes (CpGs), using Illumina 450K or EPIC/850K arrays, with FEV1, FVC, and FEV1/FVC. We performed multiancestry epigenome-wide meta-analyses (total of 17,503 individuals; 14,761 European, 2,549 African, and 193 Hispanic/Latino ancestries) and interpreted results using integrative epigenomics. Measurements and Main Results: We identified 1,267 CpGs (1,042 genes) differentially methylated (false discovery rate, <0.025) in relation to FEV1, FVC, or FEV1/FVC, including 1,240 novel and 73 also related to chronic obstructive pulmonary disease (1,787 cases). We found 294 CpGs unique to European or African ancestry and 395 CpGs unique to never or ever smokers. The majority of significant CpGs correlated with nearby gene expression in blood. Findings were enriched in key regulatory elements for gene function, including accessible chromatin elements, in both blood and lung. Sixty-nine implicated genes are targets of investigational or approved drugs. One example novel gene highlighted by integrative epigenomic and druggable target analysis is TNFRSF4. Mendelian randomization and colocalization analyses suggest that epigenome-wide association study signals capture causal regulatory genomic loci. Conclusions: We identified numerous novel loci differentially methylated in relation to pulmonary function; few were detected in large genome-wide association studies. Integrative analyses highlight functional relevance and potential therapeutic targets. This comprehensive discovery of potentially modifiable, novel lung function loci expands knowledge gained from genetic studies, providing insights into lung pathogenesis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Lee M, Huan T, McCartney DL, et al. Pulmonary Function and Blood DNA Methylation: A Multiancestry Epigenome-Wide Association Meta-analysis. Am J Respir Crit Care Med. 2022. PMID: 35536696. doi:10.1164/rccm.202108-1907OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。